Fig. 6From: Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipatedKaplan-Meier survival curves illustrating the treatment effect in one arbitrarily chosen simulation replicate of scenarios A–D, each with sample size 500. Survival pattern in the control arm and censoring pattern are derived from the GOG111 trial datasetBack to article page